Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-13.19%
operating margin TTM
-33.58%
revenue TTM
261.73 Million
revenue per share TTM
4.1$
valuation ratios | |
|---|---|
| pe ratio | -84.87 |
| peg ratio | -1.70 |
| price to book ratio | 19.06 |
| price to sales ratio | 11.33 |
| enterprise value multiple | -32.92 |
| price fair value | 19.06 |
profitability ratios | |
|---|---|
| gross profit margin | 94.38% |
| operating profit margin | -33.58% |
| pretax profit margin | -12.94% |
| net profit margin | -13.19% |
| return on assets | -5.69% |
| return on equity | -21.59% |
| return on capital employed | -18.59% |
liquidity ratio | |
|---|---|
| current ratio | 2.85 |
| quick ratio | 2.80 |
| cash ratio | 0.39 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 173.77 |
| operating cycle | 229.44 |
| days of payables outstanding | 86.69 |
| cash conversion cycle | 142.75 |
| receivables turnover | 6.56 |
| payables turnover | 4.21 |
| inventory turnover | 2.10 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.40 |
| debt equity ratio | 1.57 |
| long term debt to capitalization | 0.53 |
| total debt to capitalization | 0.61 |
| interest coverage | -2.48 |
| cash flow to debt ratio | -0.41 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.12 |
| cash per share | 9.75 |
| operating cash flow per share | -3.05 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -0.41 |
| short term coverage ratios | -4.39 |
| capital expenditure coverage ratio | -41.60 |
Frequently Asked Questions
When was the last time Blueprint Medicines Corporation (NASDAQ:BPMC) reported earnings?
Blueprint Medicines Corporation (BPMC) published its most recent earnings results on 30-10-2024.
What is Blueprint Medicines Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Blueprint Medicines Corporation (NASDAQ:BPMC)'s trailing twelve months ROE is -21.59%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Blueprint Medicines Corporation (BPMC) currently has a ROA of -5.69%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BPMC's net profit margin stand at?
BPMC reported a profit margin of -13.19% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BPMC's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.85 in the most recent quarter. The quick ratio stood at 2.80, with a Debt/Eq ratio of 1.57.